The landscape of healthcare financing globally is evolving rapidly. With rising healthcare costs, aging populations, emerging chronic illnesses, and resource limitations, traditional funding sources are no longer sufficient. Particularly acute in Africa, these challenges necessitate innovative solutions. RxPay stands at this critical intersection, offering tailored fintech and trade credit solutions to healthcare businesses, empowering them to deliver consistent, quality healthcare.
This whitepaper explores global healthcare financing trends, focusing on Africa. It covers key topics such as trade credit in healthcare, fintech’s role, public-private partnerships (PPPs), and digital innovations like blockchain and AI-driven credit models. Case studies from leading markets highlight how new financial solutions can improve healthcare access and business growth.
Global Trends and Challenges in Healthcare Financing
Healthcare costs are rising worldwide due to medical advancements, aging populations, and the growing burden of chronic diseases. In 2021, global health spending hit a record high, partly driven by government and donor responses to COVID-19. However, spending is far from equal. High-income countries, which make up only 16% of the world’s population, account for 78% of global health expenditures. In these countries, government funding and insurance cover most costs, with healthcare spending often exceeding 10% of GDP—reaching 17% in the United States, according to the American Medical Association.
In contrast, low- and middle-income countries face severe funding gaps. On average, governments fund about 62% of global health spending through taxes or insurance, but this varies widely by income level. In low-income countries, government health spending was just $8 per person in 2023, far below the estimated $60–$86 needed per capita for basic care, according to the Institute for Health Metrics and Evaluation (IHME). As a result, many health systems in these regions depend on out-of-pocket payments and external aid to function.
Financial sustainability is another global challenge. In many places, healthcare costs are rising faster than economic growth due to expensive new treatments, higher patient expectations, and demographic changes. Even wealthier countries are struggling to balance budgets while improving healthcare efficiency. Middle-income countries, in particular, face tough decisions on where to invest—whether in primary care or costly hospital infrastructure. As a result, there is growing interest in value-based care models, which tie spending to patient health outcomes rather than the number of services provided.
The need to do more with limited resources has led to new healthcare financing strategies. These include outcome-based payment contracts and investments in preventive care to reduce expensive hospitalizations. The COVID-19 pandemic underscored both the importance and fragility of healthcare financing. While many countries increased health spending during the crisis, they now face budget constraints and must balance healthcare with other priorities like infrastructure and education.
There is broad agreement that new financing solutions are needed to achieve Universal Health Coverage (UHC) without placing excessive financial burdens on individuals. The following sections will explore these solutions, particularly in the African context.
The Healthcare Financing Landscape in Africa
Africa faces major healthcare financing challenges, making it a key region for innovative solutions. Most African countries invest far below global benchmarks in health. In the 2001 Abuja Declaration, African Union nations pledged to allocate 15% of government spending to health, but few have met this target. Many sub-Saharan African countries spend only 1–5% of their GDP on health, well below the 5% minimum recommended by the WHO for adequate care. As a result, public funding covers less than half of the total health expenditures in many nations.
To fill this gap, African healthcare systems rely on two main sources: external aid and out-of-pocket (OOP) payments by households. Donor aid plays a crucial role. According to Think Global Health, in 2021, half of sub-Saharan African countries depended on external funding (grants, loans, aid) for over a third of their health budgets. However, donor assistance is expected to plateau or decline by 2050 due to shifting global priorities. Without a major increase in domestic funding, this could widen Africa’s healthcare financing gap.
A heavy reliance on OOP payments is one of Africa’s biggest healthcare challenges. The WHO reports that in most African countries, individuals and families pay directly for health services. This has severe consequences—over 200 million Africans face financial hardship from medical expenses, and more than 150 million were pushed into poverty or deeper poverty in a single year (2019) due to healthcare costs. In fact, Africa accounts for half of all people globally impoverished by health expenses. The World Economic Forum estimates that up to 11 million Africans are driven into poverty annually due to healthcare costs.
These high OOP burdens not only impoverish families but also discourage people from seeking care, worsening health outcomes. Many essential medicines and treatments remain unaffordable. When patients cannot pay, healthcare providers—clinics, pharmacies, and hospitals—struggle with revenue shortfalls, leading to medication stock-outs, underpaid staff, and declining quality of care. Without more sustainable financing solutions, Africa’s healthcare systems will continue to face deep challenges.
Another major challenge is the fragmentation and inefficiency of existing healthcare funds. Limited government budgets are often stretched across multiple priorities, and poor budget execution or delayed disbursements mean that even allocated funds don’t always reach healthcare facilities in time. This leaves many public hospitals and clinics underfunded, struggling to maintain essential services.
Meanwhile, Africa’s private healthcare sector delivers nearly 50% of healthcare services, according to the World Economic Forum. Yet, private clinics and pharmacies often face severe funding shortages. Banks consider many small and medium-sized healthcare enterprises (SMEs) too risky or too small to lend to, and there are few financial products tailored to their needs. Without access to capital, these providers struggle to buy medicines, invest in equipment, or expand services, creating a cycle of low capacity and limited revenue.
The financing gap for African health SMEs has gained attention from impact investors and global health organizations. Innovative solutions like credit guarantees, dedicated health funds, and fintech-driven credit platforms are emerging to bridge this gap.
In short, Africa’s healthcare system faces a funding crisis—underfunded public services, high out-of-pocket costs for patients, and private providers starved of capital. However, new financing approaches in trade credit, financial technology, and strategic partnerships are beginning to address these challenges, as explored in the next section.
Trade Credit: A Catalyst for Healthcare Businesses
Trade credit is a crucial but often overlooked financing tool in healthcare. It allows suppliers to provide medicines and medical equipment to buyers—such as pharmacies, hospitals, and clinics—on credit, with payments deferred for 30, 60, or 90 days. This flexibility ensures healthcare providers can maintain essential stock even when immediate cash flow is tight. For example, a pharmacy that purchases antibiotics on credit can serve patients without delay, generating revenue before repaying the supplier. This prevents stock-outs, supports patient care, and stabilizes healthcare operations.
Trade credit also strengthens collaboration along the healthcare supply chain. Suppliers offering favorable credit terms build long-term relationships with buyers, fostering trust and reliability. Pharmaceutical distributors, for instance, often extend credit to secure customer loyalty, improve inventory management, and reduce waste.
Additionally, trade credit helps healthcare businesses adapt to market shifts, such as disease outbreaks or regulatory changes. With credit as a buffer, clinics can invest in new equipment or scale up supplies without waiting for cash reserves. It also enables innovation—research labs, for example, can acquire expensive reagents on credit, driving medical advancements. In an industry where timely access to resources is critical, trade credit plays a vital role in keeping healthcare systems responsive and resilient.
In Africa, trade credit is a game-changer for healthcare providers. Historically, many African pharmacies and small clinics operate on a cash-and-carry basis, unable to procure medicines unless they pay upfront. This has contributed to frequent stock shortages and limited the range of services these facilities can offer.
Recognizing this pain point, RxPay and similar innovators provide flexible trade financing to health businesses so they can maintain inventory without upfront payment. Through RxPay’s platform, for instance, a pharmacy can apply for a trade credit line via a mobile app and quickly receive approval to purchase authenticated medicines and consumables, with repayment due after a grace period.
By providing working capital to the lower tiers of the supply chain, trade credit services help even small drug shops in Africa maintain steady stocks of essential medicines. This creates a dual impact: businesses boost revenue by meeting demand, while communities gain more reliable access to treatments.
RxPay’s trade credit program has already supported thousands of pharmacies and hospitals, with over 5,000 businesses across Nigeria, Kenya, Uganda, and beyond relying on its services. Real-world examples highlight its effectiveness—one Nigerian pharmacy used RxPay credit to stock up on antimalarials during peak malaria season, leading to a 30% increase in patients served and preventing critical stock-outs.
To mitigate the risks of non-payment inherent in trade credit, tools like trade credit insurance and data-driven credit assessments are essential. Trade credit insurance protects suppliers or financiers against the risk of buyers defaulting on payment. In the healthcare context, this insurance can give lenders (or suppliers) confidence to extend larger credit lines, knowing they are safeguarded if a hospital cannot pay due to financial distress. Additionally, the rise of fintech has enhanced credit risk management through better data. Lenders like RxPay use transaction data from pharmacies, inventory turnover, and other metrics to gauge creditworthiness in real time. This reduces default rates and allows responsible expansion of credit access.
Overall, trade credit is poised to fuel growth and innovation in healthcare, especially in Africa’s private health sector. By freeing businesses from cash constraints, it enables them to invest in quality improvement and expanded services, ultimately strengthening the healthcare system’s capacity to serve the population. RxPay’s success in Africa exemplifies how trade credit can be harnessed to achieve both commercial sustainability and public health goals.
Fintech and Digital Innovations in Healthcare Financing
Financial technology (fintech) is playing an increasingly transformative role in healthcare financing worldwide, and particularly in Africa. The continent’s fintech boom – characterized by mobile money, digital lending, and online financial services – provides a powerful platform to address healthcare’s inclusion and funding challenges. According to the World Economic Forum, Africa is now a global leader in fintech adoption, with mobile money as a cornerstone: it accounts for nearly 70% of the world’s $1 trillion mobile money transactions and close to 10% of sub-Saharan Africa’s GDP in transactions flows through mobile money services.
Fintech has transformed financial access, allowing millions of previously unbanked people and small businesses to save, borrow, and make payments using mobile phones. This digital revolution is now reshaping healthcare financing as well. Digital payment systems help patients manage medical costs through installment plans, micro insurance, and even crowdfunding. According to the CEO of PharmAccess Foundation, the same fintech solutions driving financial inclusion in Africa can also strengthen healthcare access, especially for underserved communities. With high mobile phone usage, even remote clinics and patients can now connect to health financing networks at a low cost.
One of the most promising innovations is the rise of digital health wallets and mobile insurance platforms. In Kenya, M-TIBA (developed by CarePay) provides a mobile wallet that links patients, healthcare providers, and insurers. Individuals and donor organizations can deposit funds or insurance benefits into M-TIBA, which patients use via their phones to pay for services at over 4,000 participating clinics. More than 5 million people have joined the platform, creating a cashless healthcare system that improves transparency and ensures funds are used specifically for medical care.
Digitizing financial transactions in healthcare also brings broader benefits. Platforms like M-TIBA generate real-time data on healthcare usage and spending, which helps governments and insurers plan more effectively. Meanwhile, fintech-driven microinsurance products, like those from MicroEnsure and Jamii Africa, offer low-cost health insurance via mobile phones. Users can pay premiums and receive claims directly through digital interfaces, significantly lowering administrative costs. These solutions are helping first-time insurance users protect themselves from medical expenses that could otherwise lead to financial hardship.
Fintech is also transforming lending and credit in healthcare. Traditional banks often hesitate to fund small clinics and pharmacies due to their lack of credit history or collateral. Fintech lenders are addressing this gap with alternative data-driven risk models and flexible repayment structures. The Medical Credit Fund (MCF), an Africa-focused impact investment fund, introduced a mobile-based loan product called Cash Advance. Unlike traditional loans, repayments are automatically deducted as a percentage of daily mobile money transactions, making it easier for small healthcare businesses to manage debt. Since no physical collateral is required, this model has been especially beneficial for female entrepreneurs who might not own property but still need funding to grow their businesses.
So far, MCF has disbursed $150 million in loans to over 2,000 small healthcare providers, maintaining a 96% repayment rate. This success proves that fintech-enabled credit solutions can be both financially sustainable and highly impactful, unlocking much-needed capital for healthcare businesses and improving patient access to essential services.
Similarly, RxPay’s fintech platform streamlines the credit application for pharmacies by replacing long, bureaucratic bank processes with a fast, app-based application system. Instead of waiting weeks for approval, pharmacists can apply and get a decision almost instantly, thanks to AI-powered credit scoring. This system analyzes purchase and sales data in real time, allowing for more accurate and personalized credit decisions that align with each business’s cash flow cycle. By incorporating daily sales, inventory turnover, and other transaction data alongside traditional credit metrics, AI models offer a more complete picture of a small healthcare business’s financial health. As a result, more deserving businesses qualify for credit, while lenders reduce their risk through better predictive analytics. Fintech lenders worldwide are proving that machine-learning-based credit scoring improves loan performance, making it possible to finance businesses that were once deemed “unbankable.”
Beyond lending and insurance, cutting-edge technologies like blockchain and AI are starting to reshape healthcare financing by increasing efficiency and trust. Blockchain, known for its secure and transparent record-keeping, has promising applications in healthcare payments, supply chain management, and insurance claims. In health insurance, for example, blockchain can create a tamper-proof record of claims and transactions, reducing fraud and administrative costs. One successful pilot by an insurance consortium used a blockchain-based system to provide real-time claim transparency, significantly cutting processing times and disputes.
In pharmaceutical supply chains, blockchain is being used to track drugs from manufacturer to patient, ensuring authenticity and preventing counterfeit medicines. This has financing benefits as well: when a lender or supplier can verify that a pharmacy has received a legitimate stock of drugs, they can confidently extend credit based on that inventory. Smart contracts – self-executing agreements stored on the blockchain – could eventually automate healthcare payments, instantly transferring funds from insurers to clinics once a treatment is recorded and verified.
While still in its early stages, blockchain’s ability to lower transaction costs and enhance financial traceability is attracting interest from public payers and donors. With these innovations, healthcare financing is moving toward a future where funds flow more efficiently, risks are minimized, and businesses have greater access to the capital they need to serve their communities.
AI is transforming healthcare financing beyond just credit scoring. Advanced algorithms can predict healthcare cost trends, enabling insurers to set fairer premiums and helping health systems allocate budgets more efficiently. AI can also detect billing anomalies or fraudulent insurance claims, reducing unnecessary losses. On the patient side, AI-driven apps can provide financial planning advice, helping individuals save for medical expenses or choose the best insurance coverage for their needs.
In Africa, innovators are blending AI with mobile technology to expand healthcare access. AI-powered chatbots, for instance, can triage patients and recommend affordable care options, while remote monitoring apps could potentially sync with insurers to reward users for healthy behaviors. These tools are reshaping how healthcare is financed and delivered, making essential services more accessible.
Fintech and digital innovations are breaking down financial barriers across the healthcare ecosystem. By leveraging mobile platforms, they reach underserved populations, personalize financial products through data-driven insights, and cut administrative costs with automation. For healthcare and pharmaceutical businesses, fintech offers critical working capital and new ways to accept payments, such as mobile money, which expands their customer base. Governments and large payers also gain access to real-time financial data, improving policy-making and resource allocation.
RxPay sits at the heart of these advancements. By combining AI-powered credit scoring with mobile-based fintech solutions, it efficiently delivers trade credit at scale. This model showcases how technology-driven financing can strengthen healthcare systems from the ground up, ensuring providers have the resources they need to serve their communities.
Public-Private Partnerships (PPPs) in Healthcare Funding
Public-Private Partnerships (PPPs) have emerged as a key strategy for financing and delivering healthcare worldwide. In these agreements, governments collaborate with private companies to develop and manage healthcare projects—whether building hospitals, strengthening pharmaceutical supply chains, or expanding medical services to underserved areas. The goal is simple: leverage private sector investment and expertise to advance public health goals.
For governments, particularly in resource-limited settings, PPPs offer a way to bridge funding and infrastructure gaps without bearing the full financial burden upfront. The private sector, in turn, invests capital, technology, or management expertise and receives payments over time – often based on performance or service usage. In healthcare, PPPs take different forms:
- Facility-based PPPs: A private company constructs and maintains hospitals while the government provides medical staff and funding.
- Service delivery partnerships: Private firms manage non-clinical services like diagnostic labs or pharmaceutical supply chains for the public sector.
- Global health partnerships: Large-scale collaborations between corporations, donors, and governments to fund vaccines, drug production, or health infrastructure.
Many African countries have embraced PPPs to improve healthcare access. One of sub-Saharan Africa’s first hospital PPPs, the Queen ‘Mamohato Memorial Hospital in Lesotho, provided a state-of-the-art facility but also highlighted potential risks – cost overruns placed unexpected financial strain on the government. Other initiatives have had clearer successes, such as Nigeria’s diagnostic center partnerships and Kenya’s Managed Equipment Services project, which allowed public hospitals to access high-end medical equipment like MRI machines and dialysis units through private-sector leasing agreements.
Supply chain innovations have also benefited from PPPs. Ghana and Rwanda, for instance, partnered with private logistics firms like Zipline, a drone delivery company, to distribute blood and vaccines to remote areas, ensuring life-saving treatments reach patients faster.
When structured well, PPPs can unlock large-scale investments in hospitals, laboratories, and pharmaceutical manufacturing without draining government budgets upfront. They also transfer risks—such as construction delays or inefficiencies – to the private sector, incentivizing better performance. The right private partners bring expertise, cutting-edge technology, and management strategies that can drive long-term cost savings. For patients, the impact is tangible: more hospital beds, reliable access to medicines, and life-saving services like dialysis or radiotherapy in regions where none previously existed. Done right, PPPs don’t just finance healthcare – they improve health outcomes.
However, However, PPPs are not a one-size-fits-all solution and require careful planning to succeed. As the WHO notes, while PPPs might seem to offer immediate relief to public budgets under strain, they often commit governments to substantial future payments. A hospital built by a private partner, for instance, will require the government to make availability payments for decades; if these are too costly, it can squeeze other health spending. Ensuring value for money is paramount – PPPs should be pursued only when they are more cost-effective than traditional public procurement. This requires a robust feasibility analysis and transparent bidding processes.
For public-private partnerships (PPPs) in healthcare to succeed, governments need the ability to design, enforce, and monitor contracts effectively. These agreements should clearly define performance expectations, such as maintaining low infection rates in hospitals or ensuring critical medical equipment is always functional. Without strong oversight, private partners may prioritize profits over patient care – for example, focusing on higher-paying services while neglecting those most in need.
To address these concerns, global health policy has evolved to include more innovative partnership models. One powerful approach is private-public-philanthropic partnerships (PPPPs), which bring together governments, private companies, and philanthropic organizations to fund critical healthcare initiatives. A leading example is Gavi, the Vaccine Alliance, where governments, international agencies, pharmaceutical firms, and the Bill & Melinda Gates Foundation collaborate to ensure life-saving vaccines reach low-income countries. Through tiered pricing models and guaranteed purchase agreements, private manufacturers are incentivized to produce vaccines for underserved markets – mobilizing billions of dollars for immunization efforts.
In Africa, some governments are expanding PPP models by partnering with private health providers within national health insurance schemes. In Ghana, for example, the National Health Insurance Scheme (NHIS) contracts private clinics and pharmacies to serve insured patients, expanding healthcare access beyond the limitations of public hospitals. Similarly, in Kenya and Nigeria, public health programs work with faith-based hospitals and private laboratories, funding their services under-regulated cost structures. This approach allows governments to tap into the efficiency and reach of private providers while ensuring equitable healthcare access for more people.
By aligning public funding with private sector efficiency, these partnerships have the potential to scale healthcare access sustainably. However, success depends on well-structured contracts, continuous oversight, and a commitment to equity, ensuring that private sector involvement benefits the broader population, not just those who can afford premium services.
Looking ahead, PPPs are expected to play a growing role in financing Africa’s healthcare expansion, but with an emphasis on sustainability and mutual benefit. The COVID-19 crisis spurred some emergency PPPs – such as temporary facilities and testing collaborations – showing how quickly such partnerships can be stood up in a crisis. Post-pandemic, governments are exploring PPPs to strengthen health security (for example, local vaccine manufacturing in South Africa and Senegal with private investment to reduce reliance on imports).
To succeed, these partnerships must be built on trust, transparency, and alignment of objectives. When properly executed, PPPs offer a pathway to combine public responsibility with private efficiency, unlocking funds and accelerating improvements in healthcare infrastructure and services across Africa. RxPay’s model can itself be seen as complementary to PPP efforts – by strengthening private pharmacies and clinics through financing, it boosts the overall health system that both public and private actors depend on. In fact, one could envision future PPPs where governments or donors support programs like RxPay (through guarantees or funding) to scale up credit access for health SMEs as part of a national health strategy, effectively blending public and private efforts to ensure medicines are available in every community.
Innovative Financing Models for Healthcare
Traditional healthcare financing mechanisms are struggling to keep up with increasing demand, rising costs, and the need for more efficient funding models. To address these challenges, a variety of innovative financing models are emerging, blending public, private, and philanthropic capital while introducing new incentives tied to measurable health outcomes. These approaches shift the focus from simply funding services to paying for results, leveraging private investments, and optimizing resource allocation.
One of the most promising models is outcome-based financing, which ties funding to measurable health improvements rather than just service delivery. This is best exemplified by Social Impact Bonds (SIBs) and Development Impact Bonds (DIBs). Under this approach, private investors provide upfront capital to fund healthcare initiatives—such as maternal health programs or infectious disease interventions—while governments, donors, or philanthropic organizations agree to repay the investment only if specific health targets are met. This model ensures accountability, efficiency, and a focus on impact. A notable example is Cameroon’s maternal and newborn health impact bond, which successfully increased safe deliveries in hospitals. Investors were repaid by philanthropic organizations once the predefined health improvements were achieved. Though still relatively new, impact bonds offer a compelling way to attract private capital into healthcare while ensuring that funds are used effectively.
Another innovative approach is blended finance, which strategically combines public or donor funding with private investments to reduce risk and attract larger financial contributions. This model works in several ways, including guarantee schemes, where governments or development banks provide partial guarantees for loans given by commercial banks to healthcare providers, making banks more willing to lend. Another method is matching funds, where donors or public institutions match the capital raised by health startups or healthcare providers, amplifying the impact of private-sector contributions. A successful example is USAID and the U.S. Development Finance Corporation (DFC), which have provided credit guarantees to African banks, stimulating lending to hospitals, clinics, and pharmaceutical businesses. By unlocking millions of dollars in financing, blended finance reduces dependence on donor aid while expanding access to healthcare.
Pooled financing is another impactful mechanism that combines multiple sources of funding into large-scale health initiatives rather than dispersing funds across smaller, isolated projects. This approach creates greater financial stability, long-term impact, and more efficient resource allocation. Two key examples are The Global Fund to Fight AIDS, Tuberculosis, and Malaria, which pools resources from multiple governments and private donors to combat major diseases, and The Global Financing Facility (GFF) for Maternal and Child Health, which supports country-led healthcare initiatives while attracting both donor and private investment. These pooled financing mechanisms offer transparency, scale, and long-term sustainability, making them attractive for investors and governments looking to expand healthcare coverage without overburdening state budgets.
In the pharmaceutical realm, innovative financing includes advance market commitments (AMCs) and volume guarantees, where funders commit to purchasing a certain volume of a product – such as vaccines or contraceptives – if it is developed. This model incentivizes manufacturers to expand production capacity and ensures that low-income markets have access to affordable medical supplies. A landmark example is Gavi’s AMC for pneumococcal vaccines, which accelerated vaccine availability in underserved regions by securing financial commitments from donors and industry partners. Similarly, price-sharing agreements and outcomes-based pricing are gaining traction, particularly in high-income countries. These models tie drug prices to performance—for example, paying only a portion of the cost of a cancer drug if the patient responds well or refunding the cost if the treatment fails. While currently more common in wealthier nations, these financing strategies set a precedent for value-driven healthcare investments worldwide.
For healthcare providers and businesses, alternative financing models like asset financing and leasing offer solutions to high upfront capital costs. Instead of purchasing expensive medical equipment outright, hospitals can lease or enter pay-per-use contracts, spreading costs over time while ensuring maintenance and functionality. This approach is particularly relevant in African public-private partnership (PPP) equipment schemes, where leasing enables hospitals to offer advanced diagnostics like MRI scans without overwhelming financial strain. Inventory and receivables financing are also expanding in healthcare—allowing clinics and pharmacies to access immediate cash flow by selling unpaid invoices (factoring) rather than waiting for insurers to process claims. In markets like the U.S., this type of healthcare factoring is common, and as insurance penetration grows in emerging markets, similar solutions could provide liquidity for providers facing delayed payments.
Community-based financing models are another critical innovation, particularly in resource-limited settings. In many African communities, health savings groups and cooperatives allow members to pool funds for medical expenses. This traditional system is being digitized by fintech startups, which enable individuals to contribute to shared health funds via mobile money. These solutions function like crowdfunding but within trusted networks, offering a reliable safety net for medical emergencies. At a larger scale, some governments are experimenting with diaspora bonds for health, where expatriates invest in government-backed bonds specifically earmarked for healthcare improvements in their home countries. Driven by patriotism and family welfare concerns, these bonds provide a sustainable financing mechanism for health infrastructure and services.
Several real-world case studies highlight the impact of these innovative financing models. In India, the Rajasthan Hospital Care Financing model used an impact bond structure to upgrade maternity wards, leading to improved maternal health outcomes. In the United States, major hospital systems have issued municipal bonds to fund healthcare infrastructure, borrowing from public investors with long-term repayment plans. This traditional model of hospital financing could inspire similar approaches in Africa, where adapting municipal bonds with local guarantees might help fund critical health projects sustainably. The UK’s National Health Service (NHS) implemented a Private Finance Initiative (PFI) to build hospitals, and while the approach faced challenges, it demonstrated how structured public-private investment can modernize healthcare infrastructure—offering valuable lessons for African policymakers.
In the startup ecosystem, telehealth and digital health solutions have become a major focus for venture capital investment, with billions of dollars flowing into companies developing AI-driven diagnostics, online pharmacies, and digital payment solutions. These investments indirectly enhance healthcare financing by subsidizing the development of low-cost, scalable solutions for healthcare providers and patients.
In Africa, two standout models are the PharmAccess Medical Credit Fund (MCF) and the SafeCare Initiative. The Medical Credit Fund combines philanthropic capital with development bank investments to create a revolving fund for healthcare SME loans—a model that spreads risk and enables sustainable lending. This type of blended financing could be expanded with partners like RxPay to provide trade credit to an even wider network of healthcare providers. The SafeCare initiative, meanwhile, links quality improvement in clinics to access to financing—clinics that achieve higher quality scores under SafeCare’s framework become more attractive to lenders and insurers, unlocking lower interest rates or better credit terms. By directly tying healthcare quality to financing opportunities, this model reduces risk for lenders while incentivizing continuous improvement in service delivery—a true win-win for the healthcare sector.
Ultimately, the future of healthcare financing will not rely on a single solution but a combination of approaches, tailored to specific challenges and market needs. Trade credit, fintech-driven lending, PPPs, outcome-based models, and impact investing all address different financial barriers—from daily working capital needs to large-scale infrastructure projects. The common thread across all these models is innovation—finding smarter ways to mobilize capital, align incentives, and improve health outcomes efficiently.
Technology plays a critical role across all these financing approaches. Data-driven decision-making, AI-driven risk assessment, and mobile platforms for health payments help reduce inefficiencies, lower transaction costs, and expand access to financial services for healthcare providers. RxPay is an integral part of this evolving financial landscape, offering trade credit solutions that complement public and private sector efforts. By ensuring pharmacies, hospitals, and clinics have access to the working capital they need, RxPay is helping to strengthen supply chains, improve medication availability, and support the overall resilience of Africa’s healthcare system.
Conclusion and Strategic Insights
The landscape of healthcare financing is rapidly evolving, driven by necessity and opportunity. Globally and in Africa, traditional financing approaches alone are insufficient to meet the growing demand for quality healthcare. The future points toward a hybrid financing ecosystem that leverages the strengths of various sectors: public financing provides the foundation and equity, private capital and innovation drive efficiency and scale, and technology bridges gaps in access and information. For healthcare and pharmaceutical businesses, these trends carry both promise and responsibility. On the one hand, new financing options – from trade credit lines to digital loans and PPP-driven investments – mean greater access to capital for expansion, modernization, and stocking life-saving products. On the other hand, businesses will be expected to integrate these solutions effectively, maintain transparency, and deliver on performance (whether that’s repaying credit, achieving health outcomes under a contract, or utilizing funds efficiently) to sustain the trust of financiers and partners.
For Africa, embracing these future financing models could be transformative. Reducing out-of-pocket burdens through insurance and tech-enabled pooling of funds will protect patients from catastrophic expenses and increase the utilization of services. Empowering healthcare SMEs with credit and investment will strengthen the supply chain and health infrastructure at the community level, which is crucial for resilience (as seen during COVID-19 when local clinics were the frontline). Public-private partnerships can expedite the availability of advanced care and infrastructure, but they must be pursued with rigorous planning and oversight to truly benefit the public. Fintech integration in health financing is a particularly bright spot – it has already proven to boost financial inclusion, and when directed towards health, it can unlock dormant efficiencies (for example, cutting administrative costs, as digital claims do, or improving targeting of subsidies through data).
RxPay is strategically positioned within these trends. By providing trade credit via a fintech platform, it directly addresses two key gaps: the working capital shortage in the health supply chain and the inefficiencies of old financing methods. Its model illustrates how a private-sector innovation can support public health objectives: every pharmacy prevented from stock-out by RxPay’s credit is a community better served and fewer patients turned away. As this service scales, it could dovetail with broader health system financing – for instance, national drug supply agencies could partner with RxPay to ensure that even the smallest clinics can partake in pooled procurement (with credit covering their orders), thus increasing economies of scale and lowering drug prices overall. Additionally, the data gathered by RxPay (on purchase patterns, drug demand, and repayment behavior) could become valuable for health planners and financiers, informing them where needs are greatest or which areas are ripe for insurance products. In this way, RxPay becomes more than a financer; it becomes an intelligence and capacity-building partner in the health ecosystem.
To fully realize the future of healthcare financing, several strategic insights emerge from this whitepaper:
- Integrate Financing Channels: Rigid silos between public funding, private capital, and donor support should be broken down. Blended financing strategies can amplify impact – for example, governments can use targeted subsidies or guarantees to boost initiatives like RxPay, effectively blending public interest with private efficiency.
- Leverage Technology and Data: The success of fintech in financial inclusion shows the importance of user-friendly, scalable technology. Stakeholders in health financing should invest in digital infrastructure (from national health finance databases to mobile apps for providers) to track funds, reduce leakage, and tailor products. Data should drive decision-making – whether AI credit scoring to broaden lending or health data analytics to guide outcome-based payments.
- Focus on Sustainability and Local Ownership: Innovative financing should build sustainable systems, not temporary fixes. This means strengthening local institutions – banks, insurance pools, health businesses – so that over time, they can stand on their own. International partners and investors can catalyze progress, but ultimately, domestic resource mobilization (through economic growth, improved tax collection for health budgets, and private savings for health) must increase. Think Global Health’s projections that external aid may stagnate highlight the urgency for Africa to grow its domestic health financing capacity.
- Enhance Capacity and Governance: Whether it’s managing PPP contracts or regulating digital lenders, government capacity is crucial. Training and frameworks must evolve so that health ministries, finance ministries, and regulators can keep pace with the complexity of new financing models. Good governance will attract more private investment – investors are more likely to fund health projects in countries with clear rules, respect for contracts, and reliable co-funding.
- Keep the Patient at the Center: Amid all the financing mechanisms, it is essential to remember that the end goal is better health outcomes and financial protection for people. Innovations should be assessed by how they improve access to care, quality of services, and affordability for patients. For instance, does a fintech loan to a clinic result in more patients treated? Does a PPP hospital serve the poor or only those who pay? Keeping metrics of equity and health impact at the forefront will ensure that financing innovations truly serve society.
In conclusion, the future of healthcare financing will be characterized by collaboration and innovation. No single actor can solve the challenges alone: governments provide stewardship and part of the funding, private companies like RxPay provide creativity, efficiency, and additional capital, and development partners fill gaps and build capacity. The trends outlined – from trade credit expansion to AI-driven credit models, from PPPs to blockchain transparency – all converge toward a more resilient health financing system. It is a system where a pharmacy in Lagos or Nairobi can secure the medicines it needs without going bankrupt, where a rural hospital can operate modern equipment through a fair partnership, and where families no longer have to choose between healthcare and poverty. For healthcare and pharmaceutical businesses, embracing these new models will not only drive their growth but also weave them into the broader fabric of health system strengthening. RxPay’s efforts in trade credit demonstrate the impact and viability of such models. By continuing to innovate and collaborate, RxPay and similar stakeholders will undoubtedly be key players in the next chapter of healthcare financing – one that promises a healthier, more financially secure future for communities across Africa and around the globe.
References
African Institute for Development Policy (AFIDEP). (2023, February). Status of Healthcare Financing in Africa: Despite Many Commitments, African Countries’ Domestic Investments in Health Remain Suboptimal (Factsheet). AFIDEP. Retrieved from https://afidep.org/wp-content/uploads/2024/01/Status-of-health-finaning-in-Africa.pdf
Akinjeji, A., Olanipekun, T., Adepoju, N., Dairo, M. D., Olumide, A. E., & Adejumo, P. O. (2023). Public-private partnership to rapidly strengthen and scale COVID-19 response in Western Kenya. Public Health Management & Practice, 29(1), 33–41. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC9887331/
American Medical Association. (n.d.). Trends in health care spending. Retrieved March 15, 2025, from https://www.ama-assn.org/about/research/trends-health-care-spending
Apeagyei, A. (n.d.). Africa’s health financing gap. Think Global Health. Retrieved March 15, 2025, from https://www.thinkglobalhealth.org/article/africas-health-financing-gap
Chan, K. (2024). AI in FinTech: Revolutionising Credit Risk Models. Finextra (blog). Retrieved from https://www.finextra.com/blogposting/27798/ai-in-fintech-revolutionising-credit-risk-models
Institute for Health Metrics and Evaluation. (n.d.). Health financing research library. Retrieved March 15, 2025, from https://www.healthdata.org/research-analysis/health-policy-planning/health-financing-research-library
Krugman, A. (2024, August 29). Africa’s Health Financing Gap. Think Global Health. Retrieved from https://www.thinkglobalhealth.org/article/africas-health-financing-gap
Marsh Commercial. (n.d.). Trade Credit: Fuelling Growth and Innovation in the Health & Care Sector. Retrieved 2023, from https://www.marshcommercial.co.uk/articles/trade-credit-fuelling-growth-and-innovation-in-the-health-and-care-sector/
RxPay. (2024, October 9). Empowering Africa’s Healthcare Providers with Trade Credit: How RxPay is Changing the Game [Blog post]. RxPay Blog. Retrieved from https://rxpay.io/2024/10/09/to-ensure-small-businesses-have-the-financial-backing-to-maintain-and-elevate-their-3/
Signé, L. (2024, November 15). Health care in Africa: Emerging technologies at play. Brookings Institution. Retrieved from https://www.brookings.edu/articles/health-care-in-africa-emerging-technologies-at-play/
Spieker, N. (2023, June 19). How Africa’s fintech boom can boost inclusive healthcare. World Economic Forum. Retrieved from https://www.weforum.org/stories/2023/06/africa-healthcare-fintech-mobile-technology/
World Economic Forum. (2023, June). How Africa’s fintech boom can boost inclusive healthcare. Retrieved March 15, 2025, from https://www.weforum.org/stories/2023/06/africa-healthcare-fintech-mobile-technology
World Health Organization (WHO). (2024, December 12). High health-care costs in Africa continue to push over 150 million into poverty: new WHO report (News Release). WHO Regional Office for Africa. Retrieved from https://www.afro.who.int/news/uhc-day-high-health-care-costs-africa-continue-push-over-150-million-poverty-new-who-report
World Health Organization (WHO). (2023, January 26). New WHO report lays out concrete actions for governments to optimize public–private partnerships for health (News Release). WHO Regional Office for Europe. Retrieved from https://www.who.int/europe/news/item/26-01-2023-new-who-report-lays-out-concrete-actions-for-governments-to-optimize-public-private-partnerships-for-health